Targets and Strategies Toward the Development of Alzheimer Therapeutics.- The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease.- γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease.- Inhibitors of Tau-Phosphorylating Kinases.- Microtubule-Stabilizing Agents for Alzheimer’s and Other Tauopathies.- PET Imaging Agents for Alzheimer’s Disease.